Tofacitinib
Tofacitinib (Tasocitinib) is an orally bioavailable Janus kinase (JAK) inhibitor with selectivity for JAK3, JAK2, and JAK1. It is a research compound applied in studies of rheumatoid arthritis and other immune-mediated diseases, utilizing both in vitro cellular assays and in vivo animal models to investigate JAK-STAT signaling pathways.
Product Specifications
CAS Number
477600-75-2
Product Name Alternative
Tasocitinib; CP-690550
Field of Research
Immunology & Inflammation
Purity
>98%
Bioactivity
JAK inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 100 mg/ml) or in Ethanol (up to 100 mg/ml) .
Smiles
C[C@@H]1CCN (C[C@@H]1N (C) C1=C2C=CNC2=NC=N1) C (=O) CC#N
Molecular Formula
C16H20N6O
Molecular Weight
312.4
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
(3R,4R) -4-Methyl-3- (methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino) -β-oxo-1-piperidine-propanenitrile
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS760968-01 48 Well
Human Latent-transforming growth factor beta-binding protein 2 ELISA Kit
Sign In for Pricing
View Details MBS760968-02 96 Well
Human Latent-transforming growth factor beta-binding protein 2 ELISA Kit
Sign In for Pricing
View Details MBS760968-03 5x 96 Well
Human Latent-transforming growth factor beta-binding protein 2 ELISA Kit
Sign In for Pricing
View Details MBS760968-04 10x 96 Well
Human Latent-transforming growth factor beta-binding protein 2 ELISA Kit
Sign In for Pricing
View Details